Drug · DIN 02426331
ESCITALOPRAM TABLETS
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since July 28, 2023; first marketed September 10, 2014.
- Drug Identification Number (DIN)
- 02426331
- Company (DIN owner)
- Nora Pharma Inc.Varennes, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Escitalopram N06AB10
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| ESCITALOPRAM (ESCITALOPRAM OXALATE) | 10 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- June 2, 2022: NOC 28325Abbreviated New Drug Submission (ANDS) · Administrative: Change in Product Ownership. Administrative: Licensing Agreement Between Two Companies
- September 16, 2021: NOC 26668Abbreviated New Drug Submission (ANDS) · Administrative: Change in Product Ownership. Administrative: Labelling Update (to Match Licensor)
- September 10, 2014: NOC 16049Abbreviated New Drug Submission (ANDS) · Licensing agreement between two companies
Other DINs named ESCITALOPRAM TABLETS
- DIN 02426358 · Cancelled Post Market